COMUNICATO - Diniego delle domande di autorizzazione all'immissione in commercio presentate dalla societa' Smartpractice Europe GmbH ai sensi della determina Aifa n. DG 2130/2017 del 22 dicembre 2017 e successive modifiche ed integrazioni, concernente i medicinali allergeni gia' utilizzati in Italia anteriormente al 1° ottobre 1991. (19A04827)
Estratto determina n. DG/1156/2019 del 5 luglio 2019 Con la determina n. DG/1156/2019 del 5 luglio 2019, notificata alla richiedente in data 8 luglio 2019, sono diniegate le domande di autorizzazione all'immissione in commercio, depositate dalla societa' Smartpractice Europe GmbH, Steuer-Nr.: 337/5032/1276, con sede legale in Veghestrasse 19 - 48149 Münster, Germania, afferenti al procedimento avviato con determina AIFA n. DG 2130/2017 e successive modificazioni ed integrazioni, relative ai medicinali di seguito elencati: Bioban P 1487 (nitrobutyl)morpholine/(ethylnitro- trimethylene)dimorpholine 1%, Ointment;
Bioban CS 1135 4,4-dimethyl-1,3-oxazolidine/3,4,4- trimethyl-1,3-oxazolidine 1%, Ointment;
Bioban CS 1246 7-ethylbicyclooxazolidine 1%, Ointment;
1,2- benzisothiazoline -3- one, sodium salt 0.1%, Ointment;
1,3-butandiol-dimethacrylate 2%, Ointment;
1,4-butandioldimethacrylat (BUDMA) 2%, Ointment;
1,4-butanediol diglycidyl ether 0.25%, Ointment;
1,6-hexanediol diglycidyl ether 0.25%, Ointment;
2-(2´-hydroxy-5´-methylphenyl)benzotriazole (Drometrizole) 10%, Ointment;
2-(2-aminoethoxy)ethanol 1%, Ointment;
2,2,4,4-tetrahydroxybenzophenone (benzophenone-2) 1%, Ointment;
2-ethylhexyl acrylate 0.1%, Ointment;
2-hydroxy-4-methoxy-4-methyl benzophenone 10%, Ointment;
2-hydroxyethyl methacrylate (HEMA) 1%, 2%, Ointment;
2-hydroxy-ethylacrylate 0.1%, Ointment;
2-hydroxymethyl-2-nitro-1,3%-propanediol 1%, Ointment;
2-hydroxypropyl-methacrylate 2%, Ointment;
2-mercaptobenzimidazole 1%, Ointment;
3-aminophenol 1%, Ointment;
3,4´-methyl benzylidene camphor 2%, Ointment;
4-aminoazobenzene 1%, Ointment;
4-diethylamino-2-hydroxybenzoyl-benzoic acid hexyl ester 10%, Ointment;
acetylsalicylic acid 10%, Ointment;
alpha-amylcinnamic alcohol 1%, Ointment;
alpha-hexylcinnamic aldehyde 10%, Ointment;
alpha-isomethylionone 1%, Ointment;
aluminium hydroxide 10%, Ointment;
amalgam 5%, Ointment;
amalgam alloy metals 20%, Ointment;
amaranth 0.1%, Solution;
amcinonide 0.1%, Ointment;
amidoamine (stearamidopropyl dimethylamine) 0.1%, Solution;
aminophenazone 10%, Ointment;
ammonium heptamolybdate 2%, Solution;
ammonium heptamolybdate(VI) 1%, Ointment;
aniline 1%, Ointment;
anisyl alcohol 1%, Ointment;
antimony chloride 1%, Ointment;
articane hydrochloride 1%, Ointment;
aspartame 0.1%, Solution;
atropine sulfate 1%, Solution;
azorubine 0.1%, Solution;
barley meal 10%, Ointment;
basic red 46 1%, Ointment;
beclomethasone dipropionate 0.1%, Solution;
benzisothiazolinone 0.1%, Ointment;
benzoic acid 1%, Solution;
benzoic acid 5%, Ointment;
benzydamine hydrochloride 1% e 2%, Ointment;
benzyl alcohol 1%, Ointment;
benzyl benzoate 1%, Ointment;
benzylhemiformal 1%, Ointment;
benzyl-p-hydroxybenzoate 3%, Ointment;
beryllium(II) sulfat 1%, Solution;
betamethasone 0.1%, Solution;
betamethasone-17,21 dipropionate 0.5%, Ointment;
betamethasone-17,21-dipropionate 0.1%, Solution;
betamethasone-17-valerate 0.1%, Solution;
betamethasone-17-valerate 0.12%, 1%, Ointment;
bis(dibenzyldithiocarbamato)zinc 1%, Ointment;
bis-ethylhexyloxyphenol-methoxyphenyl triazine 10%, Ointment;
bismarck brown R 0.5%, Ointment;
bisphenol A-diglycidyl-methacrylate (BIS-GMA) 2%, Ointment;
bisphenol F 1%, Ointment;
brilliant black 0.1%, Solution;
budesonide 0.01%, 0.1%, Ointment;
bufexamac 5%, Ointment;
butylhydroxyanisole (BHA) 2%, Solution;
butylhydroxytoluene (BHT) 1%, Solution;
cadmium chloride 0.5%, Ointment;
cadmium sulfate 2%, Ointment;
caine mix [A] 7%, [C] 7%, Ointment;
camphor 1%, Ointment;
cananga odorata 2% e 10%, Ointment;
carba mix 3%, Ointment;
carboxymethyl cellulose sodium 2%, Ointment;
carmine 0.5%, Solution;
carmine 2.5%, Ointment;
carvone 5%, Ointment;
cereals mix 10%, Ointment;
cesium chloride 2%, Ointment;
cetalkonium chloride 0.1%, Ointment;
Cetrimide 0.05 %, Solution;
cetylpyridinium chloride 0.1%, Ointment;
chlorhexidine diacetate 0.5%, Solution;
chlorotetracycline-HCl 1%, Ointment;
chlorphenamine maleate 5%, Ointment;
chromium...
Per continuare a leggere
RICHIEDI UNA PROVA